Intensity Therapeutics INTS
NASDAQ INTS
$3.29 +0.08 (+2.54%)
As of: Oct 2, 2026 · 11:17 AM EDT

Intensity Therapeutics (INTS) Selling, General & Administrative (2022 - 2026)

Updated

Intensity Therapeutics' Selling, General & Administrative was $1.25 million in Q2 2026, up 7.5% from $1.16 million a year earlier but down 6.0% from the prior quarter.

Analysis

Intensity Therapeutics (INTS) Selling, General & Administrative (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Intensity Therapeutics' Selling, General & Administrative was $5.4 million through Jun 30, 2026, up 7.5% year-over-year; for FY2025, it was $5.19 million, down 14.8% from FY2024.

  • Selling, General & Administrative shows a three-year compound annual growth rate of 29.0% (FY2022 to FY2025).
  • In earlier years, Selling, General & Administrative was $6.09 million in FY2024 (+72.3%), $3.53 million in FY2023 (+46.1%) and $2.42 million in FY2022.
  • Quarterly Selling, General & Administrative has moved between $362,000 (Q2 2023) and $1.93 million (Q1 2024) over five years.
  • Compared with a year earlier, Selling, General & Administrative has increased for three straight quarters, with an average decline of 2.8% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q2 2024 (growth of 316.0%); the worst was Q1 2025 (a decline of 37.5%).
  • Per Business Quant data, INTS's Selling, General & Administrative in the three quarters before Q2 2026 was $1.33 million (Q1 2026), $1.64 million (Q4 2025) and $1.18 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 Intensity Therapeutics 9.93 Mn 9.93 Mn - 1.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.25 Mn
Mar 31, 2026 1.33 Mn
Dec 31, 2025 1.64 Mn
Sep 30, 2025 1.18 Mn
Jun 30, 2025 1.16 Mn
Mar 31, 2025 1.21 Mn
Dec 31, 2024 1.24 Mn
Sep 30, 2024 1.42 Mn
Jun 30, 2024 1.51 Mn
Mar 31, 2024 1.93 Mn
Dec 31, 2023 1.55 Mn
Sep 30, 2023 1.14 Mn
Jun 30, 2023 362,000.00
Mar 31, 2023 480,000.00
Dec 31, 2022 583,034.00
Sep 30, 2022 607,113.00
Jun 30, 2022 543,830.00
API Access

Intensity Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INTS&period=max&api_key=YOUR_API_KEY